[go: up one dir, main page]

MX2023012862A - Topical composition of sclerosing agents in aqueous carriers. - Google Patents

Topical composition of sclerosing agents in aqueous carriers.

Info

Publication number
MX2023012862A
MX2023012862A MX2023012862A MX2023012862A MX2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A
Authority
MX
Mexico
Prior art keywords
ulcers
topical composition
sclerosing
sclerosing agents
aqueous carriers
Prior art date
Application number
MX2023012862A
Other languages
Spanish (es)
Inventor
Mar Mariana Guerrero
MUÑUZURI Lilia SEGURA
MUÑUZURI Gloria SEGURA
Muñuzuri Sergio Segura
Original Assignee
Mar Mariana Guerrero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mar Mariana Guerrero filed Critical Mar Mariana Guerrero
Priority to MX2023012862A priority Critical patent/MX2023012862A/en
Publication of MX2023012862A publication Critical patent/MX2023012862A/en
Priority to PCT/MX2024/050053 priority patent/WO2025089937A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención, se refiere a una composición tópica con agentes esclerosantes compuesta de un agente esclerosante químico, un agente esclerosante osmótico y Cloruro de Metilrosanilina en un portador acuoso; con propiedades antimicóticas y antimicrobianas, así como un proceso para preparar dicha invención. Además, de su uso en el tratamiento de lesiones provocadas en la hipodermis, epidermis y dermis. Como son las lesiones contusas, incisas, punzantes, quemaduras de primero, segundo y tercer grado, úlceras de grado 1, 2 y 3, úlceras varicosas, úlcera por artritis, úlceras por presión, úlceras de pie diabético, así como en cualquier ecosistema cutáneo.The present invention refers to a topical composition with sclerosing agents composed of a chemical sclerosing agent, an osmotic sclerosing agent and Methylrosaniline Chloride in an aqueous carrier; with antifungal and antimicrobial properties, as well as a process to prepare said invention. In addition, its use in the treatment of injuries caused in the hypodermis, epidermis and dermis. Such as blunt, incised, stabbing injuries, first, second and third degree burns, grade 1, 2 and 3 ulcers, varicose ulcers, arthritis ulcers, pressure ulcers, diabetic foot ulcers, as well as any skin ecosystem. .

MX2023012862A 2023-10-27 2023-10-27 Topical composition of sclerosing agents in aqueous carriers. MX2023012862A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2023012862A MX2023012862A (en) 2023-10-27 2023-10-27 Topical composition of sclerosing agents in aqueous carriers.
PCT/MX2024/050053 WO2025089937A1 (en) 2023-10-27 2024-10-02 Topical composition of sclerosing agents in aqueous carriers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2023012862A MX2023012862A (en) 2023-10-27 2023-10-27 Topical composition of sclerosing agents in aqueous carriers.

Publications (1)

Publication Number Publication Date
MX2023012862A true MX2023012862A (en) 2023-11-09

Family

ID=91375431

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023012862A MX2023012862A (en) 2023-10-27 2023-10-27 Topical composition of sclerosing agents in aqueous carriers.

Country Status (2)

Country Link
MX (1) MX2023012862A (en)
WO (1) WO2025089937A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3224940A (en) * 1961-12-18 1965-12-21 Lilly Co Eli Antacid compositions and method of using same
CA1024048A (en) * 1973-10-29 1978-01-10 Richard Sternheimer Urinary sediment stain
CN1059322C (en) * 1995-05-05 2000-12-13 周波 Processing method of polypropylene for high molecular synthetic material double-fold eyelid operation
SE520670C2 (en) * 2001-12-18 2003-08-12 Sca Hygiene Prod Ab Breathable absorbent articles with cone-shaped cavities and method of preparation
CA2892010A1 (en) * 2012-11-20 2014-05-30 Vita Naturale, Llc Compositions and methods for their dermatological use
MX2015009696A (en) * 2013-01-28 2016-03-31 Urigen Pharmaceuticals Inc Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer.
US20160244955A1 (en) * 2015-02-20 2016-08-25 Phillip Morisson Allred, III Delivery System for Cleaning & Maintaining Drains and Methods Associated Therewith
EP3501496A1 (en) * 2017-12-22 2019-06-26 Cosmo Technologies Ltd. Liquid delivery composition

Also Published As

Publication number Publication date
WO2025089937A1 (en) 2025-05-01

Similar Documents

Publication Publication Date Title
MX2020010405A (en) COMPOSITION FOR THE TREATMENT OF CHRONIC WOUNDS.
MX2023000316A (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE.
ECSP20010477A (en) SEMI-SOLID TOPICAL COMPOSITION CONTAINING AN ANTIMICROBIAL AGENT AND PYRPHENIDONE FOR THE TREATMENT OF CHRONIC SKIN DAMAGES
MX2019008123A (en) ARTICLE WITH A SOLUBLE STRUCTURE OF FIBROUS FRAME THAT INCLUDES ACTIVE AGENTS.
BR112014009713A2 (en) transdermal administration of high viscosity bioactive agents
AR058821A1 (en) GRADUABLE TREATMENT METHODS, SYSTEMS AND COMPOSITIONS BY THE USER FOR ACNE TREATMENT
EA202191212A1 (en) COMPOSITIONS AND METHODS FOR PROCESSING BIOFILMS WITHOUT INDUCING ANTI-MICROBIAL DRUG RESISTANCE
MX385380B (en) TOPICAL FORMULATION TO PROMOTE WOUND HEALING.
MX2024005303A (en) BIOTENSIOACTIVE FORMULATIONS FOR USE IN SKIN CARE AND WOUND TREATMENT.
MX2023012862A (en) Topical composition of sclerosing agents in aqueous carriers.
AR117730A1 (en) COMPOSITION FOR MUSCULAR RELAXATION
CU20160088A7 (en) PIPERIDINIL-TETRAHYDROQUINOLINAS REPLACED
MX2020005056A (en) Emulsions for the topical treatment of dermal infections and mucosal infections.
CR20160277A (en) PIPERIDINIL TETRAHYDROQUINOLINAS REPLACED
BR112014007210A2 (en) resettable occlusion plaster
CL2020002509A1 (en) Topical and transdermal delivery of an iron chelator to prevent and treat chronic wounds.
MX2022010960A (en) METHODS AND COMPOSITIONS TO TREAT CANNABIS USE DISORDER AND MITIGATE CANNABINOID WITHDRAWAL.
MX2015015379A (en) Alpha adrenergic agonists for in the treatment of tissue trauma.
AR114314A1 (en) CALCIUM CARBONATE TREATED BY SURFACE REACTION TO MODIFY THE BIOMECHANICAL PROPERTIES OF THE SKIN
MX2022010093A (en) TAFOXYPARIN FOR THE TREATMENT OF PRE-ECLAMPSIA.
CL2022003513A1 (en) Improved virucidal formulations
MX2013015222A (en) PROCESS OF OBTAINING A HYDROGEL WITH INCORPORATION OF ZINC OXIDE NANOPARTICLES WITH ANTIMICROBIAL PROPERTIES.
MX2020002358A (en) Topical compositions for the treatment of cutaneous leishmaniasis.
MX2023013963A (en) Human fibroblast growth factor 1 (fgf-1) muteins, their dimers and uses.
CL2020002050A1 (en) Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation